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Abstract
We study the global spatio-temporal patterns of influenza dynamics. This is achieved by
analysing and modelling weekly laboratory confirmed cases of influenza A and B from 138
countries between January 2006 and May 2014. The data were obtained from FluNet, the
surveillance network compiled by the the World Health Organization. We report a pattern
of skip-and-resurgence behavior between the years 2011 and 2013 for influenza H1N1pdm,
the strain responsible for the 2009 pandemic, in Europe and Eastern Asia. In particular,
the expected H1N1pdm epidemic outbreak in 2011 failed to occur (or “skipped”) in many
countries across the globe, although an outbreak occurred in the following year. We also report
a pattern of well-synchronized 2010 winter wave of H1N1pdm in the Northern Hemisphere
countries, and a pattern of replacement of strain H1N1pre by H1N1pdm between the 2009
and 2012 influenza seasons. Using both a statistical and a mechanistic mathematical model,
and through fitting the data of 108 countries (108 countries in a statistical model and 10 large
populations with a mechanistic model), we discuss the mechanisms that are likely to generate
these events taking into account the role of multi-strain dynamics. A basic understanding of
these patterns has important public health implications and scientific significance.
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1 Introduction
Seasonal influenza in temperate zones of the world are characterized by regular annual epi-
demics for most of the last fifty years[1, 2, 3]. According to historical reports, however, this
annual periodicity was less apparent in the past. Between 1855 and 1889, influenza was not
widely experienced and believed to have caused few deaths in Britain [4]. In the first half
of the twentieth century, seasonal influenza seemed “erratic as regards its occurrence in both
time and space” [5]. Between 1920 and 1944 there were 16 widespread influenza (both A and
B) epidemics in the United States, the remaining eight years presumably being complete skips
[6]. In the same period in the United States “visitations of influenza B ... tended to come
every four to six years and those of A every two to three.” [5, 4]. Similarly, while in recent
years annual outbreaks are the norm, skips by different influenza subtypes (such as A and B)
may unexpectedly occur, sometimes with one subtype temporarily replacing the other. To
add another layer of complexity, the regular seasonal dynamic experience in the last decades
can be grossly punctuated when a new pandemic virus strain appears, as was the case in 2009.
Understanding those factors that enhance annual dynamics, and those factors which break it
up is a research direction that deserves more attention. Even basic concepts concerning the
competition between strains, cross-immunity, the influence of climatic factors or the effects of
a country’s vaccination policy on the seasonal dynamics in the large, are poorly understood
to date (e.g., [7]).
To help explore these sorts of complexities, in this paper, we are interested in characterizing
the spatio-temporal dynamics of influenza as they occurred globally following the last 2009
pandemic. A generic pattern easily identified for many countries in Europe is shown in Fig. 1
e,f, and g (red). There we see the initiation of the new H1N1pdm09 (referred to henceforth
as H1N1pdm) pandemic in March 2009, followed by another major outbreak in September
2010. Unusually an H1N1pdm outbreak failed to appear at all in the “skip year” of 2011/12,
given that the strain was very new, although the outbreak returned and resurged in 2012/13.
As we will discuss shortly, this same pattern was generic to many countries across Europe,
with slight differences from country to country. A visualisation of the extraordinary skip-year
across 45 countries is given in Fig. 2.
Many of the features of the time series in Fig. 1 can be explained in terms of basic
epidemiological theory. Briefly, when the new 2009 pandemic influenza strain confronted a
large susceptible human population it was able to generate a large-scale global epidemic.
This placed in motion a succession of epidemic “waves” that followed one after the other.
Since infected individuals who recover from the disease gain temporary immunity, each new
epidemic wave also served to build up further the level of immunity in the population. In effect,
this served to reduce the number of susceptible individuals available for future infection. At
some point, when the number of available susceptibles fell below a threshold level, it became
impossible for a new outbreak of the pandemic strain to trigger. This explains the “skip” year
in 2011/12 in which the strain was mostly absent (see Fig. 2). The H1N1pdm strain resurged
in 2012/13 presumably because recovered individuals gradually lost their immunity, providing
enough new susceptibles to trigger further outbreaks. A systematic theory for understanding
epidemic oscillations and skips has been developed over the last decade [8], which we will use
to explain these long term dynamics.
Our detailed spatio-temporal analysis is based on time series obtained from FluNet, a com-
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prehensive global surveillance tool for influenza developed by the World Health Organization
(WHO) in 1997 [9], in which virological data are documented in real-time and publicly avail-
able. When discussing and presenting the FluNet data it is convenient to use the following
notation. We denote H1N1pre as the pre-2009-pandemic seasonal A strains, H1N1pdm as the
pandemic strain (H1N1pdm09) responsible for the 2009 influenza pandemic, and H3N2 as the
seasonal H3N2 strains whose original form was responsible for the 1968 influenza pandemic.
We note that FluNet has previously been employed to study the spread of influenza on
global or large-scale spatio-temporal patterns in three other studies that we know of. Finkel-
man et al. [10] studied the pre-2009-pandemic period between January 1997 and July 2006
in 19 temperate countries in both Hemispheres. They identified large scale co-existence of in-
fluenza A and B, interhemispheric synchronized pattern for subtype A H3N2, and latitudinal
gradients in the epidemic timing for seasonal influenza A. A recent study [11] that focused
on the Western Pacific Region between January 2006 and December 2010, found that dom-
inant strains of influenza A were reported earlier in Southern Asia than in other countries.
Thus, status in South Asian countries may provide early warning for other countries. Bloom-
Feshbach et al. [12] examined latitudinal variations in seasonal activity of influenza and
respiratory syncytial virus (RSV) and applied a time series model to the seasonal influenza
data from 85 countries. They found evidence of latitudinal gradients in timing, duration, sea-
sonal amplitude and between-year variability of epidemics. In terms of the temporal pattern
in a single region, Dorigatii et al. [13] studied the third wave of infection by the H1N1pdm
pandemic strain in England in the 2010/11 season. They found that increased transmissibility
and loss-of-immunity among the population may be responsible for this unexpected wave.
However, to our knowledge, no study has been conducted focusing on the global pattern of
seasonal activities of the H1N1pdm pandemic virus and interactions among different strains
based on the FluNet large-scale dataset from 2010 to 2013. This is of special interest given that
the surveillance scale was substantially improved since 2010. Such a study is important to aid
the development of strategies for relieving the burden of seasonal influenza. Understanding
the spatial pattern may be useful in a global effort to reduce the impact of a deadly influenza
pandemic. The activity of H1N1pdm still causes substantial attention in the post-pandemic
era and has led to substantial morbidity and mortality in most years since its appearance,
including 2013/14.
On the global network of influenza transmission, it is known that China and Southeast
Asia lie at the center of the global network and USA acts as the primary hub of temperate
transmission [14, 15]. The expansion of H1N1pdm during 2009 can be explained with data
on human mobility (air travel) and viral evolution[16].
2 Materials and Methods
Weekly time series of lab-confirmed cases (isolates) of influenza were obtained from FluNet
for 138 countries that have non-zero cases between January 2006 and May 2014. The analysis
included six different types of time series: i) total specimens processed, ii) H1N1pre strains,
iii) H3N2 strains, iv) H1N1pdm strain, v) un-subtyped influenza A, and vi) influenza B
(including two circulation lineages).
The number of un-subtyped influenza A is often substantial and needs to be accounted for.
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Following [10], we proportionally assigned the un-subtyped influenza A to the three subtypes
as follows. Let the number of lab-confirmed cases of subtypes H1N1pre, H1N1pdm, H3N2 and
un-subtyped A for any country in a particular week be a1, a2, a3 and a0, respectively. Then
the new revised number for each of the three subtypes was taken to be: a′i = ai + a0ai/
∑
ai
for i = 1, 2, 3.
The statistical analysis was implemented in the R programming language (http://www.r-
project.org/). We generally preferred to focus on regions (macro geographical continental
regions and geographical sub-regions) rather than their constituent countries (see Figure 1)
because aggregated regional data is less influenced by stochasticity. We observed that nearly
all countries, especially those in the temperate regions, largely followed their regional patterns.
The breakdown of countries of the eight regions used in this study may be found in the
supplementary material section S9.
To help comparisons between hemispheres it was convenient to redefine the initiation
and termination dates of calendar years in a manner that makes influenza seasons (usually
winter) line up. We therefore moved forwards the beginning and end dates that define years
for Northern Hemisphere (NH) countries to stretch from the 35th week of a calendar year to
the 34th week of the following calendar year, roughly overlapping the school calendar year.
For countries in the Southern Hemisphere (SH), the calendar year remains the reference frame.
Thus the skip-year (skip-season) of H1N1pdm is 2011/12 in NH and is 2012 in SH, see Fig. 2.
A skip-year, or simply a skip, is defined as a season with an uninitiated or minor epidemic.
What constitutes a “minor” epidemic is difficult to quantify precisely. For the purposes of this
study, we formulated the following practical quantitative comparative definition. If, after an
epidemic year the number of influenza cases drops by more than a factor of ten, we consider
this to be a skip year. We thus use the following simple measure defined for H1N1pdm:
α1 = log{(h11 + k)/(h10 + k)}, (1)
where h10, h11 are the total number of lab-confirmed cases of H1N1pdm in that region during
the 2010/11 and 2011/12 seasons, respectively. The index compares the ratio of the number
of cases in 2011/12 season to those in the 2010/11 season in NH (or 2012 to 2011 in SH). Our
criterion for a “skip” is generally that α1 < log(1/10), i.e., an order of magnitude difference.
We set k = 50 in α1 to reduce errors magnified when case numbers are small. The merit of
using skip index (which is a ratio of two years) rather than the actual number is clear. In
this way, we can remove the differences in the testing effort among countries and we can also
remove the effects of different population sizes among countries. We assume that the total
numbers of specimens processed had not varied much from year to year, which was true from
2010 to 2012.
Similarly we define skip-indices α2, α3, α4, for subtype H3N2, influenza B and total speci-
mens processed, respectively. We argue that as long as surveillance efforts and testing policies
were implemented consistently in each country between 2010 and 2013, then effects due to
differences in testing policies are removed by taking the ratio of confirmed cases over consec-
utive years. To our knowledge, there were no dramatic changes in surveillance effort in most
countries from 2010 to 2013 (as observed from the total number of specimens processed).
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3 Results
Skip-and-resurgence pattern of H1N1pdm
Figure 1 panels (a-h) show weekly aggregated lab-confirmed cases of subtypes H1N1pdm (red
triangle) and H3N2 (blue circle) in the eight geographical regions having the largest case
numbers in the period January 2009 and May 2014. A similar set of panels for thirty different
countries (having the largest number of confirmed cases) may be found in Fig. S2 in the
supplementary material. It should be emphasised that the graphs are scaled to highlight the
trends (and also accommodate the extremely high peak in 2009) by plotting the square-root of
the weekly lab-confirmed cases. The figures immediately identify a number of clear features.
With regard to H1N1pdm, we summarise here:
(i) All regions in Europe and Eastern Asia have identical trends and experienced skip-years
in 2011/12. In more detail these regions experienced two initial waves of H1N1pdm in
2009/10, followed by a single wave in 2010/11, a skip-year in the 2011/12 season and
then a reemergence of H1N1pdm in the following 2012/13 season. The skip was more
evident in Eastern/Southern Europe than Western/Northern Europe. Although the
latter experienced a minor outbreak in 2011/12, its peak was an order of magnitude
lower than the previous season, and thus by our criteria could be classified as a skip.
The size of the mini-outbreak is misrepresented and appears exaggerated due to the
square-root scaling.
(ii) In stark contrast, H1N1pdm failed to show any skip in Northern America. In fact
H1N1pdm exhibited annual oscillations in Northern America, with an early and large
wave appearing in the 2013/14 flu season.
(iii) Central America, where H1N1pdm originated, shows a different pattern to that of Eu-
rope and Eastern Asia. Instead skips occurred both in 2010/11 and 2012/13 but not in
2011/12 (Fig.1b). The dynamics over these years were essentially biennial.
(iv) South America shows an irregular pattern (Fig.1c).
With regard to H3N2 dynamics, we observe:
(i) All regions in Europe and Eastern Asia experienced significant H3N2 epidemics in
2011/12, which was a skip-year for H1N1pdm. Moreover, apart from 2012-2014, the
H3N2 dynamics were essentially negatively correlated with H1N1pdm.
(ii) In Northern America H3N2 tended to oscillate synchronously in-phase with H1N1pdm
in 2010-2012.
A spatial summary of the dynamics of each geographic region has been superimposed on the
world map of Fig. 1 panel (i). The regions colour coded in black experienced a skip year in
2011/12 and constitute a considerable proportion of the global map.
We identified 27 countries with α1 < log(1/10) and thus skip years. Total of confirmations
of the skip year was one order of magnitude lower than that of the previous year. Using a
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Figure 1: Spatio-temporal patterns of H1N1pdm and H3N2. (Panels a-h) Square-root of
weekly lab-confirmed cases of H1N1pdm (red triangle) and H3N2 (blue circle) in eight geo-
graphical regions between January 2009 and May 2014. Black arrows indicate ‘skip’ seasons
for H1N1pdm. Northern America (panel a) exhibits annual epidemics without a skip; Cen-
tral America (panel b) exhibits seemingly biennial epidemic with a skip in both 2010/11 and
2012/13 seasons; South America (panel c) is irregular in pattern; Eastern Asia (panel d)
and Europe (panel e-h) exhibit annual epidemics with a skip of H1N1pdm and a substantial
epidemic of H3N2 during the 2011/12 season. Panel (i) summarises the global pattern during
the 2011/12 season.
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higher threshold α1 < log(1/5), the number increases to 45 countries. Namely 18 countries
have α1 between log(1/10) and log(1/5). The weekly confirmations of these latter countries
are displayed in Fig. 2 (in latitude order) which gives a remarkable demonstration of the
broad geographic synchrony of the epidemic skip over the globe. We note that most of the
45 countries experienced a resurgence of H1N1pdm in 2012/13.
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Figure 2: Countries where H1N1pdm skipped the 2011/12 season (ordered in latitude order
from North to South). Countries with α1 < log 1/10 are coded in red and countries with
log 1/10 < α1 < log 1/5 are in blue.
3.1 The 2011/12 skip year and strain dynamics
Fig. 2 makes clear how the influenza dynamics of many countries are strongly correlated in
time and skip synchronously in the 2011/12 period. The time series in Figs. 1 and S2 suggest
that for nearly all countries the H1N1pdm and H3N2 cases are negatively correlated over the
full period Jan 2006 to May 2014. This is exemplified in the 2011/12 season where H1N1pdm
skipped in most countries while H3N2 outbreaks occurred in its place. To study this relation
in more detail, we tested whether these two strains are correlated across all countries in the
2011/12 season alone. That is, we asked whether countries with smaller H1N1pdm outbreaks
tend to have larger H3N2 outbreaks, in 2011/12 in NH (or 2012 in SH). Using the skip-index,
eqn. 1, our analysis showed that of the 108 countries which reported more than 500 cases of
all strains, the correlation coefficient across all countries is r = −0.61. (Without the threshold
of 500, the correlation is r = −0.63.)
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For a more detailed analysis of the 2010-2012 years, we considered a linear model with
α1 as the response, and having seven different predictors: α2 (H3N2), α3 (flu B), rank of
population size in the year 2005, rank of area, rank of absolute latitude, rank of distance from
Mexico and geographical region code. Regarding the distance from Mexico, we considerd both
Euclidean distance (defined as
√
x2 + y2 where x, y are in terms of longitude and latitude,
respectively) and effective distance [17] and found no significant difference.
α1 = c1 + c2α2 + c3α3 + c4popn.rank + c5area.rank + c6dist.rank... (2)
where the ci are constants to be fitted.
The H3N2 skip index (α2) was found to be a significant predictor (p-value < 0.001) of α1
though negatively correlated, while α3 (influenza B) was not a significant predictor (p-value
≈ 0.452). Region code and area rank were also found to be significant predictors (p-value
< 0.001 and ≈ 0.01 respectively), while all other predictors were not significant. These results
parallel our observations that in broad terms, countries in the same region share a common
pattern.
In this study, we have focused largely on the 2011/12 skip. However, it is evident from
Figure 1 of [10] and Fig.S3 in the supplementary material that H3N2 exhibited a similar
skip in 2000/01. After obtaining FluNet data for the period between 1995 and 2005 (see
supplementary material section S6) we repeated the above analysis. The H3N2 skip-index for
2000/01 season was found to be negatively correlated with both H1N1pre (r = −0.407) and
influenza B (r = −0.573) across 72 countries. With a generalized linear model (the skip-index
of H3N2 as the response and these of H1N1 and B and countries absolute latitude as factors)
both H1N1 and B were significant (p−value < 0.001). New variants of both H1N1pre and
influenza B emerged in 1999 (A/New Caledonia/20/99 and B/Sichuan/379/99, respectively),
which possibly played a role in the skip of 2000/01 for H3N2 uniformly across all countries.
It is worth noting that A/New Caledonia/20/99 had been in the vaccine components for
seven seasons. The new variant of H3N2, which may have enhanced the 2011/12 skip of
H1N1pdm in Europe and Eastern Asia, was most likely A/Perth/16/2009 (http://www.hpa.
org.uk/webc/HPAwebFile/HPAweb_C/1226908885446).
3.2 Mathematical Model
We made use of modern mathematical modelling techniques [18] to fit a stochastic single-
strain Susceptible-Exposed-Infectious-Recovered model (SEIR) to the FluNet influenza data
from 2009 until the end of 2013. Details of the model are given in the supplement section S4.
The original goal was to understand better those factors that caused the 2011/12 skip. The
model fits were made for the ten countries having the largest total confirmations since the
invasion of the strain in 2009.
The following assumptions were made when fitting the model:
• The initial susceptible proportion of the population was taken to lie between 40% and
70% for all countries rather than 100%. This takes into account that many of the elderly
population had preexisting cross-reactive antibodies[19]. In addition it was found that
the cross-protection provided by the pre-pandemic vaccine was as high as 19% [20].
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• The transmission rate β(t) was taken to be seasonal and modelled by a periodic function
of time, with a period of one year. Weather variations and school terms are understood
to be responsible for the seasonal variability [21, 22]. We adopted a seven-node cubic
spline function, and fixed the parameter of node seven to be equal to node one. The
function is second-order differentiable except for the seventh node. Thus there were six
free parameters in transmission rate β(t).
• The reporting rate ρ(t) of each country was modelled by a three-piece step function of
the following form:
ρ(t) =

ρ1, t ∈ [2009-1-1, 2009-6-11]
ρ2, t ∈ (2009-6-11, 2009-8-31]
ρ3, t ∈ (2009-8-31, 2014-2-28]
(3)
Here, 2009-6-11 is the date WHO announced the initiation of the 2009 pandemic and
2009-8-31 is the end of the 2008/09 flu season and the start of 2009/10 flu season. This
allows for the sudden increase of the reporting rate during the 2009 pandemic. For
example, the reporting rate changed dramatically during 2009 in the UK [13] and in
Canadian provinces[23, 24].
• If the infection dies out in a country after the invasion in the simulation, we introduced a
single infected individual. This mimics the transmission of influenza between countries,
so that no country is completely isolated.
• The latent period (σ−1) of the disease was assumed to to be one day and the infectious
period (γ−1) two days.
• We also fit the duration of the immunity (λ−1) by calculating the maximum log like-
lihood profile for it. Namely we fixed the duration to eight discrete values spanning
from 1.5 to 7 years, and maximized the performance of the model while fitting other
parameters. Then from this profile we estimated λ−1, and its 95% confidence interval
[18].
The model essentially finds the best fitting estimates of the transmission rate and report-
ing ratio (as defined above) to the influenza A time series by maximizing the relevant log
likelihood. The output of the model is a plot of the profile log likelihood as a function of
the duration of immunity. For example, Fig.3 shows the best fitting model to the FluNet
time series data (plotted in black) from ten countries when aggregating influenza A (i.e., by
combining H1N1/99 data with H3N2. The inset figure plots the likelihood profile and shows
that the maximum occurs when the immunity duration (λ−1) is approximately two years in
most countries, which is biologically reasonable [25].
We plot time series of the median value of reported cases for 1000 model simulations. The
median values are plotted in red, while the grey shaded region indicates the 95% confidence
interval. The median values sit close to the observed values (black lines) for all ten countries.
The fitted reporting ratio is shown in the top-left corner, and the estimated transmission
rate is shown as a solid blue curve. The simulations match most of the observed waves for
all ten countries. The estimated seasonal amplitudes in the transmission rate are small and
largely consistent across countries, which suggests that the post-pandemic waves are largely
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due to loss-of-immunity and its associated replenishment of the susceptible pool (possibly
impacted by dynamical resonance [26]). The estimated reporting ratio is very small and
varied considerably across countries. Recall that in [13], it was found that only 0.7% infected
individuals actually visit a General Practitioner. If we accept Dorigatti et al’s [13] estimation
of GP visits (0.7%) and examine all ten countries, we find that between 1/50 to 2/3 (median
1/14) of GP visits of infected individuals led to positive lab-confirmations, depending on the
country in the post-pandemic period.
We also attempted to use the same model for fitting single strain data including H1N1pdm
alone and H3N2 alone. However, when modelling a single strain (either H1 or H3), fits were
generally poor. In particular, the model was unable to predict the skip in 2011/12 for any
country. Since the main shortcoming of the model used is that it is only single strain, we
conclude that a multi-strain model that includes the interaction between the H1N1pdm and
H3N2 strains is needed to capture the 2011/12 skip.
Synchrony Patterns
We examined the synchrony pattern across Northern Hemisphere (NH) countries (latitude
> 29◦) for the three strains, H1N1 (combined H1N1pdm and H1N1pre), H3N2, and influenza
B. We focused on the period from Jan 2006 to May 2014.
In order to quantify synchrony, following [10] we made use of the Mean Confirmation
Time index, or MCT. The MCT for country-j, is the mean time of infection of all infected
persons over the course of the epidemic under examination. Thus, if in country-j there are
ni confirmations in the wi th week of a season for a particular strain, then
MCTj =
∑
i
niwi/
∑
i
ni. (4)
If all countries have the same MCT, so that MCTj = c is the same constant for each
country-j, then the distribution of the MCTj is just a single spike indicating that the countries
are highly synchronized. Obviously, the smaller the standard deviation amongst the different
MCTj the more synchronized are the different countries. The synchrony analysis examines
the distribution of MCTj over all countries j = 1, 2, ..., N (median and standard deviation)
for different strains and different seasons. Countries with no cases were removed from the
analysis. The results are shown in Fig. 4 and listed in Table S1. We examined the NH
countries and for this purpose grouped H1N1pre and H1N1pdm together as H1N1.
Fig. 4 show that countries were more synchronized by H1N1pdm than by H3N2 or in-
fluenza B in 2010/11 and 2012/13. Indeed, from Table S1 in the supplementary material, the
standard deviation of MCT for the H1N1pdm strain in the 2010/11 and 2012/13 seasons were
significantly smaller than the other seasons and any of the other strains. This may reflect a
more efficient transmissibility of the H1N1pdm virus which allows it to spread more rapidly
between countries. These findings corroborate what is observed by eye in Fig. 2 and Fig. S1,
and that the MCT of H1N1 only varies by some 5 weeks across all countries. Note that the
median of MCT of influenza B seems larger than the two influenza A strains (by two weeks),
suggesting that the flu B epidemic lagged behind the other two flu A strains [10].
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Figure 3: Fitting an SEIR model to influenza A confirmations in 10 countries. Panel a, a
flowchart of the model. Panel (b-k), the results in 10 countries. The inset panel shows the
profile log likelihood for the duration of immunity. Each panel shows the simulation (red)
versus the observed (black), with the best fitting parameters. The blue curve shows the
estimated transmission rate in the unit of basic reproductive number. The dotted vertical
lines indicate the two timings for the reporting ratio changes. The simulations are median
values for each week of 1000 simulations and shaded region show the 95% range.
Patterns of Strain Replacement
Table 1: Annual Total Confirmations of H1N1pre and Total Specimens Processed
year 2006 2007 2008 2009 2010 2011 2012 2013 2014
H1N1/07 13268 18983 29807 37879 709 41 3 5 17
Specimens 355834 513430 671232 2290733 1186197 1270287 1350542 1672204 810570
Table 1 lists the annual total confirmations of H1N1pre. It is interesting to note that the
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Figure 4: Distribution of Mean Confirmation Time for three strains, H1N1 (H1N1pre and
H1N1pdm), H3N2 and Influenza B, in North Hemisphere in eight flu seasons.
2008 total (pre-pandemic) was double that in 2006, which was due to an increase in testing
effort (total specimens processed). The high number in 2009 was most likely due to the
extensive testing during the pandemic. The numbers decreased quickly after 2009 suggested
that H1N1pre was replaced by H1N1pdm [27] The low numbers in 2012-2014 are likely to be
errors, either misclassification or mis-input. For example, six cases of H1N1pre were reported
in Poland in the 7th week of 2014. However, close observation revealed that there were minor
epidemics of both H1N1pdm and H3N2 in that period, yet data was unexpectedly missing in
these categories. But despite its presence anywhere else, six cases of H1N1pre were recorded
suggesting possible misdiagnosis. No evidence for an epidemic of H1N1pre after 2011 has
been found so far. It is interesting to note that the original form of the H1N1pre subtype had
an unusual re-emergence in 1977 some 20 years after its disappearance[28].
4 Discussion
Fundamental epidemiological principles are able to explain the skip dynamics seen in Figs. 1
and 2 in relatively simple terms. When the new strain H1N1pdm first appeared in March 2009,
the population at large had no previous exposure to the strain. This allowed the pandemic
to develop into a global-scale epidemic even though outside the normal influenza season in
many countries. With the passage of time, each successive epidemic outbreak exposed the
population at large further to the new H1N1pdm strain, thereby building up population
immunity and reducing the number of susceptible individuals [13]. Thus by the end of 2011/12,
the susceptible pool of individuals available for infection had reduced below a critical threshold
level, so that the epidemic failed to trigger over the 2011 winter season. In epidemiological
parlance, by “burning out” the available susceptible pool, the virus effectively reduced the
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reproductive number R0 below unity making it impossible for the epidemic to initiate in the
2011/12 season. This set the stage for the opportunist H3N2 virus to outcompete and replace
H1N1pdm, thus accounting for the H3N2 outbreak at the end of 2011. Fig.1 makes clear
the complex interaction between the H1N1pdm and H3N2 strains as they compete for the
available pool of susceptible individuals as well as offer cross-protection.
It is interesting that in Central America where H1N1pdm first appeared, the outbreak
progression was different to the above pattern. Two skip-seasons were observed in 2010/11
and 2012/13 (see Mexico in Fig. S2). These skips were in all likelihood an outcome of the
same underlying process, namely a burn-out of susceptibles from the previous waves.
Other mechanisms such as climatic variation, poor surveillance and results of new births
unlikely played a key role here. There were no previous studies showing that these factors
favor H3N2 rather than H1N1pdm. These factors are largely the same between Europe and
Northern America.
The occurrence of skips gives information regarding the loss-of-immunity (strain specific)
in the population, particularly if there might be only a single viral strain, or if the viral strain
is stable and evolves only at a relatively slow rate. The latter is the case for the H1N1pdm
strain which is believed to have been antigenically stable since its emergence in 2009 [29]. As
an indication of its stability, the vaccine component against H1N1pdm recommended by the
WHO and the United States Food and Drug Administration (FDA) was not updated since
fall of 2009, while those vaccine components against H3N2 and influenza B have been updated
more than twice already (see S7). If the H1N1pdm strain was indeed stable over these last
years, and the virus evolved relatively slowly, then the main source of new susceptibles in
the population was largely derived through natural loss of immunity. In these circumstances,
the resurgence of H1N1pdm in 2012/13 after the skip in 2011/12 should be viewed as a
consequence of the natural loss-of-immunity in the population [25].
The differences in influenza dynamics between Northern America (no skip) and Europe
(skip) given that they share many common factors with regard to economics, culture, climate
and latitude are in some respects surprising. We speculate the different dynamics may be
connected with the influenza vaccination coverage which was consistently higher in Northern
America than in Europe (and the rest of the world). High coverage of vaccination (against
H3N2) among general population could have slowed down the transmission of H3N2, thus
saved H1N1pdm from skip a year in Northern America. Vaccination coverage has been con-
sistently close to 40% in the United States and 30% in Canada, but less than 30% in Europe
(see supplementary material section S5) and other parts of the world, for example 14% in
Hong Kong (http://www.chp.gov.hk/) (see the skip in Hong Kong in S2). Also intriguing is
that many parts of Northern America and Central America had much higher attack rates of
H1N1 in 2009 and influenza-associated mortality in 2009 was almost 20-fold higher in some
countries in America than in Europe (see [30]). Additional work is still needed to understand
which factors are responsible for the different spatio-temporal patterns of influenza seen in
Europe and America.
Our attempts to fit the time series of aggregated influenza A confirmed cases using the
same simple SEIR model are shown in Fig. 3 and are reasonably well given that they capture
the different trends observed in ten different countries. That the same SEIR model repro-
duced the different trends suggests that the dynamics of influenza epidemics have a large
degree of determinism and the model is considerably robust. Moreover this indicates that
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the the key assumptions behind the SEIR model are largely being met. Namely, the classical
mathematical concept of infection being spread by a randomly mixing population and mean
field dynamics appear to apply when modelling large real human populations. The different
features of each country’s influenza A time series can be explained through a change in the
SEIR model’s parameters. It is also interesting that the model fits (likelihood profiles) indi-
cate a reasonably fast loss of immunity in the vicinity of 2-4 years. This could explain the
fast susceptible buildup required during skip years, which would be necessary to generate the
resurgent epidemics observed in the following years.
Our analysis has given interesting insights into the global patterns of the invasion of
H1N1pdm, which first appeared as a pandemic and then, within a few years, apparently out-
competed and completely replaced the H1N1pre seasonal flu strain. The synchrony between
countries of the H1N1pdm outbreaks is striking particularly as witnessed in the highly visi-
ble skip (Fig. 2), where for a large number of countries, H1N1pdm failed to outbreak in the
2011 flu season. Moreover, the synchrony between countries in H1N1pdm outbreak years was
also considerably strong (see Fig.3). The FluNet data gave a comprehensive picture of these
phenomenon as they evolved in time over several years, and also in space over 138 countries.
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Supplementary Materials
S1 Synchrony Pattern
Figure S1 shows the spatio-temporal patterns of weekly lab-confirmed cases of four types of
influenza strains from 35 countries chosen for having the largest total number of cases between
January, 2006 and May, 2014. Panels (a) to (d) from top to bottom show the patterns
of H3N2, H1N1pdm, H1N1pre, and Flu B, respectively. Countries were listed according
to their latitudes from north to south (data from http://thematicmapping.org/downloads/
world_borders.php).
From Table S1, the standard deviation (sd) of MCT for the H1N1pdm strain in the
2010/11 and 2012/13 seasons are significantly smaller than the other seasons and any of the
other strains. In particular, not only the sd of MCT for H1N1pdm in the 2010/11 season is
small, but also the total confirmation is high and the number of countries involved is large.
Thus globally the 2010/11 wave of H1N1pdm was very substantial and well-synchronized.
Thus the countries are more synchronized by H1N1 than by H3N2 or influenza B. This may
reflect a more efficient transmissibility of the H1N1pdm virus which allows it to spread more
rapidly between countries. These findings corroborate what is observed by eye in Figure 2.
Note that the median of MCT of flu B seems larger than the two flu A strains (by two weeks),
suggesting that the flu B epidemic lagged behind the other two flu A strains [10].
S2 Spatio-temporal Plots of Individual Countries
Figure S2 shows individual plots of 30 populations with the largest number of lab-confirmed
cases of H1N1pdm and H3N2 between January, 2009 and May, 2014.
There are several countries, such as Japan, which skipped both 2011/12 and 2012/13
season. Australia did show sign of skip in the 2012 season. Its skip index is between 1/10 and
1/5. The vaccination coverages in the general population in Australia and Japan were low.
S3 To Find Countries with Regular Annual Patterns
We consider the weekly influenza A lab-confirmations for each country from 1997 to 2013. If
there were zeros in the first few years of the time series, these zero time points will be removed.
All NA’s in the middle are treated as zeros. Then we apply spectrum function in R (version
2.15.2) to the time series. We set span=(3,5), which are the widths of the modified Daniell
smoother. We set other parameters at default values (such as taper=0.1). We compare the
heights of the spectrum at frequency f = 1 and f < 1, if the height at f = 1 is at 1.75 times
of the mean level of f < 1, we conclude the time series show regular annual patterns.
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Figure S1: Spatio-temporal patterns of lab-confirmed cases of four types of influenza strains
from 35 countries between January, 2006 to May, 2014. Countries are listed from north to
south. Grey scale shows the weekly lab-confirmed cases. The horizontal axis is time in weeks.
Evident synchrony patterns for H1N1pdm, H3N2 and influenza B can be seen in the temperate
countries. H1N1pdm showed skip in most countries in Eastern Asia and Europe during the
2011/12 season. H1N1pre was replaced by H1N1pdm after the 2009 pandemic. Isolated cases
of H1N1pre after 2011 are likely due to errors.
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Table S1: Synchrony Indicators
Indicator Season H1N1 H3N2 Flu B
Median of MCT
2006 - 07 25.2 25.9 27.9
2007 - 08 23.7 27.0 27.8
2008 - 09 47.1 25.5 29.7
2009 - 10 13.0 14.8 29.2
2010 - 11 23.4 22.4 25.0
2011 - 12 27.4 27.9 29.6
2012 - 13 25.8 25.8 28.1
2013 - 14 27.2 27.7 28.2
Standard Deviation of MCT
2006 - 07 4.39 3.32 4.48
2007 - 08 4.21 6.23 3.73
2008 - 09 8.51 7.51 5.05
2009 - 10 2.47 9.80 8.41
2010 - 11 2.54 5.53 3.51
2011 - 12 5.59 4.04 3.67
2012 - 13 2.14 4.02 3.09
2013 - 14 2.97 3.73 4.01
Total Confirmations
2006 - 07 16011 25747 11250
2007 - 08 24325 22431 28564
2008 - 09 136679 35955 23299
2009 - 10 387667 14778 28678
2010 - 11 103534 59937 56730
2011 - 12 10014 84767 45449
2012 - 13 59003 108912 69134
2013 - 14 122365 40099 42082
Number of Countries
2006 - 07 30 34 30
2007 - 08 40 28 38
2008 - 09 47 42 45
2009 - 10 48 30 39
2010 - 11 55 44 54
2011 - 12 37 55 51
2012 - 13 56 53 56
2013 - 14 53 54 48
S4 Mathematical Model and Likelihood Functions
We consider a compartmental (Susceptible-Exposed-Infectious-Recovered) model in the main
text,
S˙ = λR− β(t)SI − v(t)S (5a)
E˙ = β(t)SI − σE (5b)
I˙ = σE − γI (5c)
R˙ = γI − λR + v(t)S (5d)
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Figure S2: Weekly lab-confirmations of H1N1pdm and H3N2 in 30 populations. Black arrows
indicate ‘skip’ seasons for the H1N1pdm, when the weekly confirmations of H1N1pdm were
evidently low or absent.
where S, E, I, and R denote the proportions of susceptible, exposed, infectious and recovered
proportions in a population, and S + E + I + R = 1; In particular, Exposed refers to those
infected but not yet infectious; λ, β(t) and v(t) denote rates of individuals moving from Re-
covered to Susceptible (due to loss-of-immunity), the transmission rates of the virus, and the
vaccination rate (individuals moving from Susceptible to Recovered, after taking account into
the effectiveness of the vaccine and the delay between the vaccination and being effective of
the vaccine). σ (and γ) denotes the rates of individuals moving from Exposed (and Infectious)
to Infectious (and Recovered).
It would be very challenging to disentangle β(t), λ and v(t), given that we assume β(t)
is time-varying. Mathematically, v(t) can be transferred into as a variation in the β(t) [31].
But we can roughly estimate the v(t) from other sources (e.g. number of vaccines delivered
and the time of the vaccination etc). For simplicity in this manuscript, we set v(t) = 0, and
leave this challenging task to future works.
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The weekly report cases is a weekly integral in the form
Zt =
∫
aweek
ρ(t)γIdt (6)
We assume that the observed weekly lab-confirmations Ct is a random sample from a Negative-
binomial (NB) distribution
Ct ∼ NB
(
n =
1
τ
, p =
1
1 + Ztτ
)
(7)
where n and p denote the size and probability of the NB distribution (R version 2.15.2),
and τ denotes an over-dispersion parameter which will be estimated. (In the sense that the
NB can be viewed as an over-dispersed Poisson process.) The mean and variance of the NB
distribution,
mean =
n(1− p)
p
= Zt (8a)
variance =
n(1− p)
p2
= Zt(1 + Ztτ) (8b)
When τ = 0, the NB distribution is reduced to a Poisson distribution. Thus the likelihood
for the week (lt) can be simply calculated, namely the probability of observing Ct, given Zt
and τ , under the NB distribution [32]. The overall likelihood function is
L(θ|C0,...,N) =
N∏
t=0
lt (9)
where θ denotes the parameter vector. We used iterated filtering to estimate the maximum
likelihood estimates for θ. This methodology has been extensively studied and used in a
number of publications [33, 34, 23, 35, 36, 18, 37]
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S5 Influenza Vaccination Coverage in Different Coun-
tries
Table S2: Estimated influenza vaccination coverage in the general population
Country/
Population group 2008-09 2009-10 H1N1pdm (2009-10) 2010-11 2011-12
Austria 3
Bulgaria 4.74 6.33 3.41 2.91
Cyprus 11.8 16.1 3 11.9 12.05
Czech Republic 7.2 7.8 0.6
Denmark NA
England NA
Estonia 3 1.3
Finland 50
France 20.6 8
Germany 28.1 26.6 8
Greece 3
Hungary 27 10.2 10.3
Iceland 16.2 17.7 46 14.9 14.2
Ireland 23
Italy 19.1 19.6 4 17.2 17.8
Latvia 0.9 0.8 0.5 0.4
Lithuania 7.8 4 3 6.4
Luxembourg 16.6 18.1 6
Malta 23
The Netherlands 21.9 22.4 30 21.3 65.7
Norway 12 12(13) 45 12 9
Poland 4.1 3.1 3.1 4.5
Portugal 15 15(19) 6 17.5 16.4
Romania - 5.2 9 5.6 3
Slovakia 12.8 12.4 0.4 9.1 7.5
Slovenia 7.3 7.3 5 4.89
Spain 27
Sweden 59
Source:
http://venice.cineca.org/Final_Seasonal_Influenza_Vaccination_Survey_2010.pdf
http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20064
http://ecdc.europa.eu/en/escaide/materials/presentations%202010/escaide2010_late_
breakers_mereckiene.pdf
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Table S3: Influenza vaccination coverage in U.S. (> 6 months) and Canada (> 12 years old)
Country 2009-2010 (seasonal) H1N1pdm 2009-2010 (combined) 2010-11 2011-12
US 41.2 27.2 47.8 43.0 41.8 (47.6?)
Canada 32.2 41.3 NA 30.2 28.9
Source:
http://www.cdc.gov/flu/professionals/vaccination/coverage_0910estimates.htm.
http://www.statcan.gc.ca/pub/82-003-x/2010004/article/11348/tbl/tbl01-eng.htm,
http://www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/health101b-eng.htm
In Japan, a study in four wards (communities) and one city in Tokyo showed that, among
those between age 18 and 65, 38.1% received seasonal influenza vaccine and 12.1% received
A(H1N1pdm) influenza vaccine between October, 2009 and April, 2010 [38]. The vaccination
coverage for H1N1pdm in Hong Kong is around 14% http://www.dh.gov.hk/.
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S6 Spatio-temporal Pattern from 1995 to 2005
Figure S3 shows the spatio-temporal pattern of three strains from 1995 to 2005, and that of
the weekly total specimens processed.
S7 Vaccine Components
Influenza virus vaccine composition is an indicator of predicted dominance of influenza strains.
Table S4 shows the influenza virus vaccine composition recommended by the Food and Drug
Administration (FDA) of the United States (http://www.fda.gov/BiologicsBloodVaccines/
GuidanceComplianceRegulatoryInformation/Post-MarketActivities/LotReleases/ucm062928.
htm), which is usually the same as the recommendation by the World Health Organiza-
tion for the north hemisphere countries (http://www.who.int/influenza/vaccines/virus/
recommendations/en/).
http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/SeasonalInfluenza/
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Figure S3: Spatio-temporal patterns of lab-confirmed cases of three types of influenza strains
and total specimens processed for 44 countries which reported the largest confirmations be-
tween January, 1995 and December, 2005. Countries are listed in order of their latitudes.
Grey scale shows the weekly lab-confirmed cases after taking square root. The horizontal axis
is time in weeks.
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Table S4: Influenza vaccine composition recommended by U.S. Food and Drug Administration
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S8 Comparison among the US, UK and Canada
Figure S4 shows the comparison of the standardized weekly confirmations among the United
States, United Kingdom and Canada populations. These comparisons suggest that the attack
rate in 2009 might be low in UK than in North America.
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Figure S4: Comparison of the population standardized weekly confirmations between US, UK
and Canada for H1N1pdm and H3N2.
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S9 A list of countries
Regions and sub-regions are from http://millenniumindicators.un.org/unsd/methods/m49/
m49regin.htm.
Table S5:
name subregion pop2005 latitude
Mauritius Eastern Africa 1241173 -20.255
Madagascar Eastern Africa 18642586 -19.374
Zambia Eastern Africa 11478317 -14.614
Mozambique Eastern Africa 20532675 -14.422
United Republic of Tanzania Eastern Africa 38477873 -6.270
Rwanda Eastern Africa 9233793 -1.998
Kenya Eastern Africa 35598952 0.530
Uganda Eastern Africa 28947181 1.280
Ethiopia Eastern Africa 78985857 8.626
Angola Middle Africa 16095214 -12.296
Democratic Republic of the Congo Middle Africa 58740547 -2.876
Congo Middle Africa 3609851 -0.055
Cameroon Middle Africa 17795149 5.133
Central African Republic Middle Africa 4191429 6.571
Chad Middle Africa 10145609 15.361
Sudan Northern Africa 36899747 13.832
Egypt Northern Africa 72849793 26.494
Algeria Northern Africa 32854159 28.163
Morocco Northern Africa 30494991 32.706
Tunisia Northern Africa 10104685 35.383
South Africa Southern Africa 47938663 -30.558
Cote d’Ivoire Western Africa 18584701 7.632
Ghana Western Africa 2253501 7.960
Sierra Leone Western Africa 5586403 8.560
Togo Western Africa 6238572 8.799
Nigeria Western Africa 141356083 9.594
Guinea Western Africa 9002656 10.439
Guinea-Bissau Western Africa 1596929 12.125
Burkina Faso Western Africa 13933363 12.278
Senegal Western Africa 1177034 15.013
Cape Verde Western Africa 506807 15.071
Mali Western Africa 1161109 17.350
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Table S6:
name subregion pop2005 latitude
Niger Western Africa 1326419 17.426
Mauritania Western Africa 2963105 20.260
United States Northern America 299846449 39.622
Canada Northern America 32270507 59.081
Saint Lucia Caribbean 16124 13.898
Martinique Caribbean 395896 14.653
Guadeloupe Caribbean 438403 16.286
Saint Martin Caribbean 0 18.094
Jamaica Caribbean 2682469 18.151
Dominican Republic Caribbean 9469601 19.015
Cuba Caribbean 11259905 21.297
Panama Central America 3231502 8.384
Costa Rica Central America 4327228 9.971
Nicaragua Central America 5462539 12.840
El Salvador Central America 6668356 13.736
Honduras Central America 683411 14.819
Guatemala Central America 12709564 15.256
Mexico Central America 104266392 23.951
Argentina South America 38747148 -35.377
Uruguay South America 3325727 -32.800
Chile South America 16295102 -23.389
Paraguay South America 5904342 -23.236
Bolivia South America 9182015 -16.715
Brazil South America 186830759 -10.772
Peru South America 27274266 -9.326
Ecuador South America 13060993 -1.385
Colombia South America 4494579 3.900
French Guiana South America 192099 3.924
Suriname South America 452468 4.127
Venezuela South America 26725573 7.125
Kyrgyzstan Central Asia 5203547 41.465
Uzbekistan Central Asia 26593123 41.750
30
Table S7:
name subregion pop2005 latitude
Kazakhstan Central Asia 15210609 48.160
China Eastern Asia 1312978855 33.420
Japan Eastern Asia 127896740 36.491
Korea, Republic of Eastern Asia 47869837 36.504
Mongolia Eastern Asia 2580704 46.056
Sri Lanka Southern Asia 19120763 7.612
India Southern Asia 1134403141 21.000
Bangladesh Southern Asia 15328112 24.218
Bhutan Southern Asia 637013 27.415
Nepal Southern Asia 27093656 28.253
Pakistan Southern Asia 158080591 29.967
Iran (Islamic Republic of) Southern Asia 69420607 32.565
Afghanistan Southern Asia 25067407 33.677
Indonesia South-Eastern Asia 226063044 -0.976
Singapore South-Eastern Asia 4327468 1.351
Malaysia South-Eastern Asia 25652985 4.201
Philippines South-Eastern Asia 84566163 11.118
Cambodia South-Eastern Asia 13955507 12.714
Thailand South-Eastern Asia 63002911 15.700
Lao People’s Democratic Republic South-Eastern Asia 566391 19.905
Viet Nam South-Eastern Asia 85028643 21.491
Oman Western Asia 2507042 21.656
Qatar Western Asia 796186 25.316
Bahrain Western Asia 724788 26.019
Jordan Western Asia 5544066 30.703
Israel Western Asia 6692037 31.026
Iraq Western Asia 27995984 33.048
Syrian Arab Republic Western Asia 18893881 35.013
Turkey Western Asia 72969723 39.061
Azerbaijan Western Asia 8352021 40.430
Armenia Western Asia 3017661 40.534
Georgia Western Asia 4473409 42.176
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Table S8:
name subregion pop2005 latitude
Bulgaria Eastern Europe 7744591 42.761
Romania Eastern Europe 21627557 45.844
Hungary Eastern Europe 10086387 47.070
Republic of Moldova Eastern Europe 3876661 47.193
Slovakia Eastern Europe 5386995 48.707
Ukraine Eastern Europe 46917544 49.016
Czech Republic Eastern Europe 10191762 49.743
Poland Eastern Europe 38195558 52.125
Belarus Eastern Europe 9795287 53.540
Russia Eastern Europe 143953092 61.988
United Kingdom Northern Europe 60244834 53.000
Ireland Northern Europe 4143294 53.177
Lithuania Northern Europe 3425077 55.336
Denmark Northern Europe 5416945 56.058
Latvia Northern Europe 2301793 56.858
Estonia Northern Europe 1344312 58.674
Norway Northern Europe 4638836 61.152
Sweden Northern Europe 9038049 62.011
Finland Northern Europe 5246004 64.504
Iceland Northern Europe 295732 64.764
Malta Southern Europe 402617 35.890
Greece Southern Europe 11099737 39.666
Spain Southern Europe 43397491 40.227
Portugal Southern Europe 10528226 40.309
Albania Southern Europe 3153731 41.143
The former Yugoslav Republic of Macedonia Southern Europe 2033655 41.600
Italy Southern Europe 5864636 42.700
Serbia Southern Europe 9863026 44.032
Bosnia and Herzegovina Southern Europe 3915238 44.169
Croatia Southern Europe 455149 45.723
Slovenia Southern Europe 1999425 46.124
France Western Europe 60990544 46.565
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Table S9:
name subregion pop2005 latitude
Switzerland Western Europe 7424389 46.861
Austria Western Europe 8291979 47.683
Luxembourg Western Europe 456613 49.771
Belgium Western Europe 10398049 50.643
Germany Western Europe 82652369 51.110
Netherlands Western Europe 1632769 52.077
New Zealand Australia and New Zealand 4097112 -42.634
Australia Australia and New Zealand 20310208 -24.973
New Caledonia Melanesia 234185 -21.359
Fiji Melanesia 828046 -17.819
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